{"transactions":[{"id":2233088,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T00:41:42.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":13882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13882,"derivative":{"exercise_price":8.1,"exercise_date":"2023-06-10","expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":13882},"source":{"system":"sec-edgar","filing":"0001077183-22-000108","document":"wf-form4_165525367136668.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000108/wf-form4_165525367136668.xml","form_type":"4"}},{"id":2233087,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T00:41:42.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":15556,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17179,"source":{"system":"sec-edgar","filing":"0001077183-22-000108","document":"wf-form4_165525367136668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000108/wf-form4_165525367136668.xml","form_type":"4"}},{"id":2344896,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Chief Operating"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-08T19:03:38.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the achievement of certain performance targets by December 31, 2022, 25% of the option shares will vest and become exercisable on March 4, 2023, and the remaining option shares will vest and become exercisable in 36 equal monthly installments thereafter as the Reporting Person continues to provide services to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":7.5,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-017287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122017287/doc4.xml","form_type":"4"}},{"id":2344895,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Chief Operating"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-08T19:03:38.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable in 48 equal monthly installments measured from March 4, 2022."}],"balance_after":0,"derivative":{"exercise_price":7.5,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-017287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122017287/doc4.xml","form_type":"4"}},{"id":2515980,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-12T22:19:23.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":1945,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1945,"derivative":{"exercise_price":43.39,"exercise_date":"2022-06-02","expiration_date":"2028-06-02","underlying":"Common Stock","underlying_shares":1945},"source":{"system":"sec-edgar","filing":"0001077183-21-000247","document":"wf-form4_163675554239042.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000247/wf-form4_163675554239042.xml","form_type":"4"}},{"id":2515979,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T22:19:23.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":1623,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1623,"source":{"system":"sec-edgar","filing":"0001077183-21-000247","document":"wf-form4_163675554239042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000247/wf-form4_163675554239042.xml","form_type":"4"}},{"id":4237811,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-10T16:06:10.000Z","date":"2017-08-09","kind":"exercise","acquired":false,"shares":46872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on December 5, 2014 and is exercisable (i) with respect to 25% of the shares subject to the options, on November 30, 2015, and (ii) with respect to 6.25% of the shares subject to the option, on each subsequent three month period beginning February 28, 2016 until fully vested."}],"balance_after":28128,"derivative":{"exercise_price":22.24,"expiration_date":"2024-12-05","underlying":"Common Stock","underlying_shares":46872},"source":{"system":"sec-edgar","filing":"0001209191-17-048408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117048408/doc4.xml","form_type":"4"}},{"id":4237810,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-08-10T16:06:10.000Z","date":"2017-08-09","kind":"sale","acquired":false,"shares":46872,"price":39.5,"value":1851444.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $40.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":116261,"source":{"system":"sec-edgar","filing":"0001209191-17-048408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117048408/doc4.xml","form_type":"4"}},{"id":4237809,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-08-10T16:06:10.000Z","date":"2017-08-09","kind":"exercise","acquired":true,"shares":46872,"price":22.24,"value":1042433.28,"ownership":{"direct":true},"balance_after":163133,"source":{"system":"sec-edgar","filing":"0001209191-17-048408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117048408/doc4.xml","form_type":"4"}},{"id":4260863,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:01:30.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":1035,"price":38.84,"value":40199.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":116261,"source":{"system":"sec-edgar","filing":"0001209191-17-044354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044354/doc4.xml","form_type":"4"}},{"id":4260862,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:01:30.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":2452,"price":38.84,"value":95235.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":117296,"source":{"system":"sec-edgar","filing":"0001209191-17-044354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044354/doc4.xml","form_type":"4"}},{"id":4260861,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:01:30.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":2829,"price":38.84,"value":109878.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on June 30, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported the restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015.  As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":119748,"source":{"system":"sec-edgar","filing":"0001209191-17-044354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044354/doc4.xml","form_type":"4"}},{"id":4292920,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-06-05T16:01:55.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":555,"price":38.3,"value":21256.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on May 31, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014.  As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":122577,"source":{"system":"sec-edgar","filing":"0001209191-17-037656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117037656/doc4.xml","form_type":"4"}},{"id":4335220,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-05-03T16:01:19.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":24550,"price":35.8,"value":878890.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in equal quarterly installments over a three-year period with the first installment vesting on August 1, 2017."}],"balance_after":123132,"source":{"system":"sec-edgar","filing":"0001209191-17-029595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117029595/doc4.xml","form_type":"4"}},{"id":4358226,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:04:26.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":2070,"price":31.96,"value":66157.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported the restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016.  As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":98582,"source":{"system":"sec-edgar","filing":"0001209191-17-025569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117025569/doc4.xml","form_type":"4"}},{"id":4404020,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T16:02:29.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":541,"price":25.12,"value":13589.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on February 28, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on February 28, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":100652,"source":{"system":"sec-edgar","filing":"0001209191-17-017389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117017389/doc4.xml","form_type":"4"}},{"id":4498503,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:06:19.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":2370,"price":18.49,"value":43821.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":101193,"source":{"system":"sec-edgar","filing":"0001209191-17-001959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001959/doc4.xml","form_type":"4"}},{"id":4498502,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:06:19.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":2727,"price":17.41,"value":47477.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 30, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $17.41 to $17.60, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":103563,"source":{"system":"sec-edgar","filing":"0001209191-17-001959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001959/doc4.xml","form_type":"4"}},{"id":4533359,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-12-05T16:02:15.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":564,"price":19.95,"value":11251.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 30, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 30, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $19.91 to $19.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":106290,"source":{"system":"sec-edgar","filing":"0001209191-16-153308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116153308/doc4.xml","form_type":"4"}},{"id":4584384,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-10-05T16:04:15.000Z","date":"2016-10-04","kind":"sale","acquired":false,"shares":2045,"price":23.65,"value":48364.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $23.31 to $23.72, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported the restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":106854,"source":{"system":"sec-edgar","filing":"0001209191-16-144862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116144862/doc4.xml","form_type":"4"}},{"id":4611086,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":126230,"kind":"person","name":"Daly David","position":1,"cik":"0001320267","reported_name":"Daly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-09-06T16:23:47.000Z","date":"2016-09-01","kind":"sale","acquired":false,"shares":551,"price":20.48,"value":11284.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on August 31, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on August 31, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":108899,"source":{"system":"sec-edgar","filing":"0001209191-16-140050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116140050/doc4.xml","form_type":"4"}}]}